EDGAR Filing Documents for 0001144204-19-027349

Form 8-K - Current report:

SEC Accession No. 0001144204-19-027349

Filing Date

2019-05-20

Accepted

2019-05-20 17:30:25

Documents

Period of Report

2019-05-16

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	tv522073_8-k.htm	8-K	36914
2	EXHIBIT 1.1	tv522073_ex1-1.htm	EX-1.1	95458
3	EXHIBIT 4.1	tv522073_ex4-1.htm	EX-4.1	98731
4	EXHIBIT 4.2	tv522073_ex4-2.htm	EX-4.2	99135
5	EXHIBIT 5.1	tv522073_ex5-1.htm	EX-5.1	10821
6	EXHIBIT 10.1	tv522073_ex10-1.htm	EX-10.1	228055
7	EXHIBIT 10.2	tv522073_ex10-2.htm	EX-10.2	225035
8	EXHIBIT 10.3	tv522073_ex10-3.htm	EX-10.3	146920
9	EXHIBIT 99.1	tv522073_ex99-1.htm	EX-99.1	12494
10	GRAPHIC	tv522073_ex5-1img01.jpg	GRAPHIC	7927
11	GRAPHIC	image_001.jpg	GRAPHIC	11327
	Complete submission text file	0001144204-19-027349.txt		981772

Mailing Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932

Business Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932 (608) 441-8120

Cellectar Biosciences, Inc. (Filer) CIK: 0001279704 (see all company filings)